We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

276 hedge funds and large institutions have $3.04B invested in Pacira BioSciences in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 105 increasing their positions, 82 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 26

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

28% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 82

11% more capital invested

Capital invested by funds: $2.75B → $3.04B (+$298M)

7% more funds holding

Funds holding: 259 → 276 (+17)

3.11% more ownership

Funds ownership: 110.52% → 113.63% (+3.1%)

67% less call options, than puts

Call options by funds: $1.67M | Put options by funds: $5.08M

Holders
276
Holders Change
+17
Holders Change %
+6.56%
% of All Funds
4.25%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
46
Increased
105
Reduced
82
Closed
26
Calls
$1.67M
Puts
$5.08M
Net Calls
-$3.42M
Net Calls Change
-$7.42M

Top Buyers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
+$24.6M
2
AC
Armistice Capital
New York
+$20.7M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$14.7M
4
Marshall Wace
Marshall Wace
United Kingdom
+$10.5M
5
HCM
Hodges Capital Management
Texas
+$9.26M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$20.5M
2
Wells Fargo
Wells Fargo
California
-$18M
3
NPIC
Neumeier Poma Investment Counsel
California
-$16.2M
4
Goldman Sachs
Goldman Sachs
New York
-$14.3M
5
TA
Tamarack Advisers
California
-$7.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Qube Research & Technologies (QRT)
176
Qube Research & Technologies (QRT)
United Kingdom
$469K -$42.3K -768 -9%
OQS
177
Occudo Quantitative Strategies
Florida
$455K -$417K -7,559 -50%
Rafferty Asset Management
178
Rafferty Asset Management
New York
$449K +$17.2K +312 +4%
LPL Financial
179
LPL Financial
California
$436K +$57K +1,033 +17%
PA
180
Profund Advisors
Maryland
$435K +$7.06K +128 +2%
HW
181
Hancock Whitney
Mississippi
$422K -$2.81K -51 -0.7%
KeyBank National Association
182
KeyBank National Association
Ohio
$395K – – –
JF
183
Jump Financial
Illinois
$389K +$356K +6,463 New
ACM
184
Aubrey Capital Management
United Kingdom
$379K – – –
Zurich Cantonal Bank
185
Zurich Cantonal Bank
Switzerland
$378K +$127K +2,302 +58%
MOACM
186
Mutual of America Capital Management
New York
$366K +$8.71K +158 +3%
BFG
187
Bouchey Financial Group
New York
$331K – – –
Man Group
188
Man Group
United Kingdom
$316K +$289K +5,244 New
HSA
189
Hussman Strategic Advisors
Maryland
$313K -$55.1K -1,000 -16%
Commonwealth Equity Services
190
Commonwealth Equity Services
Massachusetts
$304K +$279K +5,054 New
P
191
Pitcairn
Pennsylvania
$303K +$386 +7 +0.1%
SW
192
SVB Wealth
Massachusetts
$301K – – –
AAM
193
Azzad Asset Management
Virginia
$287K -$1.1K -20 -0.4%
Walleye Trading
194
Walleye Trading
New York
$286K +$263K +4,761 New
CGH
195
Crossmark Global Holdings
Texas
$278K -$308K -5,590 -55%
CAM
196
ClariVest Asset Management
California
$269K – – –
MCM
197
Maryland Capital Management
Maryland
$264K +$26.4K +479 +12%
Franklin Resources
198
Franklin Resources
California
$251K +$5.4K +98 +2%
II
199
Inspire Investing
Idaho
$248K +$5.02K +91 +2%
Mitsubishi UFJ Asset Management
200
Mitsubishi UFJ Asset Management
Japan
$236K +$212K +3,852 New
6 7
8
9 10

PCRX Hedge Fund Activity: Q4 2021 in Review

276 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q4 2021, worth a combined $3.04B — up 11% from $2.75B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new PCRX positions and 26 closed out — a net gain of 20 holders — while 105 added to existing stakes and 82 trimmed.

The largest buyer was Paulson & Co, adding an estimated $24.6M. The largest seller was Deerfield Management, cutting an estimated $20.5M.

  • 276 institutional investors held Pacira BioSciences (PCRX) as of Q4 2021, up from 259 in Q3 2021.
  • Funds reported $3.04B of Pacira BioSciences stock for Q4 2021, up 11% quarter-over-quarter.
  • 46 funds opened new Pacira BioSciences positions in Q4 2021 and 26 closed out, a net change of +20 holders.
  • The largest Pacira BioSciences buyer in Q4 2021 was Paulson & Co, an estimated $24.6M added.
  • The largest Pacira BioSciences seller in Q4 2021 was Deerfield Management, an estimated $20.5M sold.

Based on aggregated 13F filings for Q4 2021.